BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2806210
Number of visits today
772
Number of downloads
2058662
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Nasonov EL, Korotaeva TV. Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology. Naučno-praktičeskaâ revmatologiâ 2022;60:131-148. [DOI: 10.47360/1995-4484-2022-131-148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nasonov EL, Feist E. The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). Naučno-praktičeskaâ revmatologiâ 2022;60:505-518. [DOI: 10.47360/1995-4484-2022-505-518] [Reference Citation Analysis]
2 Vorobyeva LD, Korotaeva TV, Loginova EY, Korsakova YL, Gubar EE, Nasonov EL. Impact of tofacitinib on patient-reported outcomes in patients with psoriatic arthritis. Data from the real clinical practice. Naučno-praktičeskaâ revmatologiâ 2022;60:334-340. [DOI: 10.47360/1995-4484-2022-334-340] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345